
About Molecular Designs
Molecular Designs is a Healthcare company based in Birmingham (United States) founded in 2019. Molecular diagnostic kits are developed for detecting various diseases. Molecular Designs has completed 1 acquisition, including Lamda Biotech. Its chief executive, as recorded, is Ted Kramm. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include DermTech, NeuMoDx and Biomeme; 3 of its 3 listed competitors have raised funding.
Company details
Molecular Designs was founded in 2019 in Birmingham, United States, within the biotechnology sector focused on diagnostics. Molecular diagnostic kits are created for identifying a broad spectrum of diseases through established PCR methods. Multiplexed assays are designed to pinpoint pathogens and swiftly detect disease indicators. Test panels are provided to assess infectious diseases, supporting clinical and research applications in the region.
- Headquarters Birmingham, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website moleculardesigns.com
- Social LinkedIn
- Investments & Acquisitions
People of Molecular Designs
21 people are tracked at Molecular Designs (13 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Ted Kramm | CEO | Leadership |
Marty Sampson | IT Director And Security Officer | Leadership |
Mark Brown | Vice President Of Sales | Leadership |
Peyton Hawkins | VP Of Operations | Leadership |
Chris C. | Director Of Infrastructure & Security | Leadership |
Todd Speranzo | Chief Commercial Officer (cco) | Leadership |
Blair Walker | Associate Director Of R&d | Leadership |
Caroline Canon Becker | HR Business Partner | Leadership |
Nicole Kincaid | Human Resource Director | Leadership |
Michael Clark | CEO | Leadership |
Greer Massey | Chief Scientific Officer | Leadership |
Jeslyn Metcalf Nicodemus | Director Of Customer Success | Leadership |
Benton Mahaffey | VP Of Finance | Leadership |
Lorena Dittmar | Senior Sales Tax Accountant | Team |
Kevin Gillmore | Accounts Payable Specialist | Team |
Lauren Doles | Operations Manager | Team |
Brad Engel | Corporate Controller | Team |
Shamik Das | Senior Scientist | Team |
Lara Self | Quality Assurance Manager | Team |
Nathan McWain | Scientist III - Process Analytics | Team |
1 more people are available in the full profile.
Complete people profiles for Molecular Designs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Designs
Molecular Designs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lamda Biotech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Kits and assays are supplied to the life science community. | lamdabio.com | Saint Louis, United States | 2006 | Sep 2024 | β’β’β’β’ |
Complete acquisition details for Molecular Designs
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Molecular Designs
2 dated milestones of Molecular Designs across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Designs is founded.
- Acquisition Acquires Lamda Biotech.
Competitors of Molecular Designs
Molecular Designs has 3 listed competitors in our database, 3 of them funded. They include DermTech, NeuMoDx and Biomeme.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dermtech.com | 1996 | San Diego, United States | $24.37M | 259 | Adhesive patch biopsies for skin cancer detection are provided. | |
| neumodx.com | 2012 | Ann Arbor, United States | $66.04M | 125 | Developer of a platform for low cost molecular testing | |
| biomeme.com | 2013 | Philadelphia, United States | $6.2M | 202 | Smartphone-based DNA detection platform is developed for diagnostics. |
Detailed competitors of Molecular Designs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Molecular Designs
The website of Molecular Designs (moleculardesigns.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 11.4% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Molecular Designs (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Molecular Designs
Complete news archive for Molecular Designs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Designs
Molecular Designs was founded in 2019.
Molecular Designs is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
Ted Kramm is the CEO of Molecular Designs, as recorded in our data.
Molecular Designs was founded in 2019 in Birmingham, United States, within the biotechnology sector focused on diagnostics. Molecular diagnostic kits are created for identifying a broad spectrum of diseases through established PCR methods. Multiplexed assays are designed to pinpoint pathogens and swiftly detect disease indicators. Test panels are provided to assess infectious diseases, supporting clinical and research applications in the region.
Molecular Designs has made 1 acquisition, including Lamda Biotech.
